In this study, we show that IFN-γ-iMSC-EVs repress AD primarily by inhibiting the expression of Th2 cytokine receptors (i.e., IL-4Rα, IL-13Rα1, and IL-31Rα) and their downstream signaling mediators. This evidence concerns the gene IL4R and Alzheimer disease.